Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2011

Jan 31, 2011

34301_dirs_2011-01-31_8055c56a-1720-4ecb-9c53-4088c490e62c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2011-01-27

Reporting Person: SHIRAHAMA NORIO SEIJIRO (President - Asia Pacific)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-01-27 Employee Stock Option $5.57 A 47500 Acquired 2021-01-27 Common Stock (47500) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common stock 10200 Direct